BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2960216)

  • 1. Tumor cell-platelet-endothelial cell interactions and prostaglandin metabolism.
    Honn KV; Menter DG; Onoda JM; Steinert BW; Diglio CA; Taylor JD; Sloane BF
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():981-5. PubMed ID: 2960216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis.
    Menter DG; Steinert BW; Sloane BF; Taylor JD; Honn KV
    Cancer Res; 1987 May; 47(9):2425-32. PubMed ID: 3552214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study.
    Menter DG; Harkins C; Onoda J; Riorden W; Sloane BF; Taylor JD; Honn KV
    Invasion Metastasis; 1987; 7(2):109-28. PubMed ID: 3294727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells.
    Curwen KD; Gimbrone MA; Handin RI
    Lab Invest; 1980 Mar; 42(3):366-74. PubMed ID: 6244462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prostacyclin on tumor cell-induced platelet aggregation.
    Menter DG; Onoda JM; Taylor JD; Honn KV
    Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of cancer cell stickiness, a model for the testing of in vivo thrombocyte aggregation inhibitors. IV. Effect of sulfinpyrazone].
    Gastpar H
    Fortschr Med; 1978 Sep; 96(36):1823-7. PubMed ID: 700559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human endothelial cells inhibit granulocyte aggregation in vitro.
    Zimmerman GA; Klein-Knoeckel D
    J Immunol; 1986 May; 136(10):3839-47. PubMed ID: 3009611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic cell attachment to and invasion of vascular endothelium and its underlying basal lamina using endothelial cell monolayers.
    Nicolson GL; Irimura T; Nakajima M; Estrada J
    Symp Fundam Cancer Res; 1983; 36():145-67. PubMed ID: 6382504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.
    Eldor A; Vlodavsky I; Fuks Z; Muller TH; Eisert WG
    Thromb Haemost; 1986 Dec; 56(3):333-9. PubMed ID: 3551181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cells produce a lipoxygenase derived chemo-repellent which influences platelet/endothelial cell interactions--effect of aspirin and salicylate.
    Buchanan MR; Butt RW; Magas Z; van Ryn J; Hirsh J; Nazir DJ
    Thromb Haemost; 1985 Jun; 53(3):306-11. PubMed ID: 3931280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification and morphologic demonstration of reactive oxygen species produced by Walker 256 tumor cells in vitro and during metastasis in vivo.
    Soares FA; Shaughnessy SG; MacLarkey WR; Orr FW
    Lab Invest; 1994 Oct; 71(4):480-9. PubMed ID: 7967504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombogenic properties of the vessel and their inhibition].
    Cazenave JP; Klein-Soyer C; Beretz A
    Nouv Rev Fr Hematol (1978); 1982; 24(3):167-71. PubMed ID: 6752880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of prostaglandin I2 production from bovine aortic endothelial cells by serum amyloid A and its N-terminal tetradecapeptide.
    Shainkin-Kestenbaum R; Zimlichman S; Lis M; Preciado-Patt L; Fridkin M; Berenheim J
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):101-6. PubMed ID: 9575350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis.
    Honn KV; Tang DG; Grossi IM; Renaud C; Duniec ZM; Johnson CR; Diglio CA
    Exp Cell Res; 1994 Jan; 210(1):1-9. PubMed ID: 8269984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats.
    Tei K; Kawakami-Kimura N; Taguchi O; Kumamoto K; Higashiyama S; Taniguchi N; Toda K; Kawata R; Hisa Y; Kannagi R
    Cancer Res; 2002 Nov; 62(21):6289-96. PubMed ID: 12414659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet cancer cell interaction in metastasis formation. Platelet aggregation inhibitors: a possible approach to metastasis prevention.
    Gastpar H; Ambrus JL; Ambrus CM
    Prog Clin Biol Res; 1982; 89():63-82. PubMed ID: 7111310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR; Ramwell PW
    Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
    Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
    Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose corticosteroids and cell-cell interactions.
    Kjellström BT; Risberg B
    Acta Chir Scand Suppl; 1985; 526():37-47. PubMed ID: 3911707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of vitamin E on immune triggered, granulocyte mediated endothelial injury.
    Boogaerts MA; Van de Broeck J; Deckmyn H; Roelant C; Vermylen J; Verwilghen RL
    Thromb Haemost; 1984 Feb; 51(1):89-92. PubMed ID: 6372154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.